HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazufumi Katayama Selected Research

S18-000003

3/2019A novel RORĪ³t inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazufumi Katayama Research Topics

Disease

8Inflammation (Inflammations)
01/2020 - 08/2002
7Neoplasms (Cancer)
01/2021 - 08/2003
6Colitis
01/2020 - 11/2002
6Insulin Resistance
05/2006 - 07/2002
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020 - 11/2002
3Infections
01/2018 - 12/2010
2Psoriasis (Pustulosis Palmaris et Plantaris)
03/2019 - 06/2008
2Allergic Rhinitis
12/2018 - 01/2017
2Rheumatoid Arthritis
06/2008 - 07/2002
2Crohn Disease (Crohn's Disease)
06/2008 - 10/2003
2Ulcerative Colitis
10/2003 - 08/2002
2Arthritis (Polyarthritis)
08/2002 - 07/2002
1Autoimmune Diseases (Autoimmune Disease)
03/2019
1Seasonal Allergic Rhinitis (Hay Fever)
01/2017
1Immune System Diseases (Immune Disorders)
01/2017
1Communicable Diseases (Infectious Diseases)
11/2012
1Mitochondrial Diseases (Mitochondrial Disease)
10/2012
1Porcine Reproductive and Respiratory Syndrome (PRRS)
07/2011
1Fetal Death
06/2011
1Liver Diseases (Liver Disease)
02/2011
1Hypersensitivity (Allergy)
01/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2005
1Hepatitis
12/2004
1Hepatocellular Carcinoma (Hepatoma)
12/2004
1Coinfection
08/2004
1Chronic Disease (Chronic Diseases)
06/2004
1Reperfusion Injury
08/2002
1Septic Shock (Toxic Shock Syndrome)
08/2002

Drug/Important Bio-Agent (IBA)

7PPAR gammaIBA
05/2006 - 07/2002
5AntigensIBA
01/2021 - 11/2012
5LigandsIBA
10/2003 - 07/2002
4Proteins (Proteins, Gene)FDA Link
10/2012 - 08/2002
4Dextrans (Dextran)FDA Link
01/2012 - 11/2002
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2012 - 11/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2008 - 05/2003
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2003 - 07/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2003 - 07/2002
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2003 - 07/2002
2VaccinesIBA
01/2021 - 11/2012
2LipidsIBA
01/2021 - 05/2014
2Interleukin-17 (Interleukin 17)IBA
01/2020 - 03/2019
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 05/2014
2CytokinesIBA
01/2020 - 12/2010
2AllergensIBA
12/2018 - 01/2017
2Neutralizing AntibodiesIBA
01/2018 - 06/2004
2MicroRNAs (MicroRNA)IBA
05/2011 - 01/2011
2Pharmaceutical PreparationsIBA
02/2011 - 11/2002
1ODN2006IBA
01/2021
1ProMune (CpG 7909)IBA
01/2021
1Protein Subunit VaccinesIBA
01/2021
1OligodeoxyribonucleotidesIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021
1S18-000003IBA
03/2019
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
03/2019
1InterleukinsIBA
03/2019
1Capsid Proteins (Capsid Protein)IBA
01/2018
1AntibodiesIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1microsomal triglyceride transfer proteinIBA
05/2014
1HSP110 Heat-Shock ProteinsIBA
05/2014
1DNA (Deoxyribonucleic Acid)IBA
11/2012
1IntegrinsIBA
10/2012
1ElementsIBA
10/2012
1Histones (Histone)IBA
10/2012
1Mitochondrial DNA (mtDNA)IBA
10/2012
1ChromatinIBA
10/2012
1Carrier Proteins (Binding Protein)IBA
10/2012
1Pattern Recognition ReceptorsIBA
07/2011
1Firefly LuciferasesIBA
06/2011
1Red Fluorescent ProteinIBA
06/2011
1Interleukin-1 (Interleukin 1)IBA
12/2010
1IgE Receptors (Fc epsilon RI)IBA
01/2009
1Dehydroepiandrosterone (DHEA)IBA
12/2004
1Small Interfering RNA (siRNA)IBA
08/2004
1Tetracycline (Achromycin)FDA LinkGeneric
08/2004
1ChemokinesIBA
08/2003
1Chemokine CCL27IBA
08/2003
1Interleukin-11 Receptors (Interleukin 11 Receptor)IBA
08/2003
1Tyrosine (L-Tyrosine)FDA Link
08/2002
1Rosiglitazone (Avandia)FDA Link
07/2002
13-nitrotyrosineIBA
07/2002
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2002
1Pioglitazone (Actos)FDA Link
07/2002
1NF-kappa B (NF-kB)IBA
07/2002

Therapy/Procedure

5Therapeutics
01/2011 - 08/2002
1Topical Administration
03/2019
1Intravenous Administration
02/2011